# FDA Inspection 1196891 - Biomat USA, Inc - January 26, 2023

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/5b4653fa-45ae-4aec-be66-db60a933f46d
Source feed: FDA_Inspections

> FDA Inspection 1196891 for Biomat USA, Inc on January 26, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1196891
- Company Name: Biomat USA, Inc
- Inspection Date: 2023-01-26
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1196891 - 2023-01-26](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/2fef5aaf-61a5-4bcc-abda-387cc679167f)
- [FDA Inspection 1016266 - 2017-04-28](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/4704da54-c35e-4a21-b285-7a56d9213741)
- [FDA Inspection 902266 - 2014-10-30](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/ec0535f0-5496-4208-bcf3-750bdb159127)
- [FDA Inspection 808134 - 2012-11-08](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/a91a77d8-292b-4f03-9ede-de56872bad14)
- [FDA Inspection 567141 - 2009-03-05](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/36ae0dd3-ee97-4c0b-9a28-cc3ef272304c)

Company: https://www.keypedia.com/companies/biomat-usa-inc/83ff43b9-c893-4af9-8e31-5f8f13b84831

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d